Related Experiment Videos
[AIDS in a child with a LAV/HTLV-III infected mother]
Insights
A child born to an HIV-infected mother developed AIDS and died from Pneumocystis pneumonia at 7 months. Despite high immunoglobulin levels, cellular immunity showed minor changes, with declining HIV antibodies observed over time.
Area of Science:
- Pediatric Immunology
- Viral Pathogenesis
- Clinical Medicine
Background:
- Human T-lymphotropic virus type III (HTLV-III) infection in mothers poses a risk to newborns.
- Vertical transmission of viruses can lead to pediatric Acquired Immunodeficiency Syndrome (AIDS).
Observation:
- A 7-month-old infant born to an HTLV-III infected mother presented with a clinically uneventful course initially.
- The infant developed Pneumocystis carinii pneumonia, leading to a fatal outcome.
Findings:
- Immunological evaluation revealed significantly elevated immunoglobulin levels.
- Minor alterations in cellular immunity were noted.
- Infant initially possessed HTLV-III antibodies, mirroring the mother's, which decreased to borderline levels during the illness.
Implications:
- This case highlights the varied clinical presentations of pediatric AIDS.
- Understanding immune responses in vertically infected infants is crucial for managing HIV/AIDS.
- Further research into immune modulation in pediatric HIV is warranted.
Abstract:
The clinical course of AIDS in a child of a HTLV III virus infected drug addicted mother is reported. Aged 7 month the baby died from Pneumocystis carinii pneumonia. The clinical course prior to the final lethal infection was remarkably uneventful. Immunological controls revealed strikingly high immunoglobulin values, whereas only minor changes of cellular immunity were observed. At birth the baby had HTLV III antibodies as her mother, which dropped during the course of the disease to borderline values.